Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oramed Pharmaceuticals (ORMP) Assets Average (2022 - 2025)

Oramed Pharmaceuticals (ORMP) has disclosed Assets Average for 3 consecutive years, with $174.7 million as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Assets Average fell 9.79% year-over-year to $174.7 million, compared with a TTM value of $174.7 million through Sep 2024, down 9.79%, and an annual FY2023 reading of $191.1 million, changed N/A over the prior year.
  • Assets Average was $174.7 million for Q3 2024 at Oramed Pharmaceuticals, down from $193.9 million in the prior quarter.
  • Across five years, Assets Average topped out at $225.7 million in Q4 2023 and bottomed at $158.0 million in Q2 2023.
  • Average Assets Average over 3 years is $181.2 million, with a median of $171.0 million recorded in 2022.
  • The sharpest move saw Assets Average surged 38.45% in 2023, then decreased 9.79% in 2024.
  • Year by year, Assets Average stood at $163.0 million in 2022, then soared by 38.45% to $225.7 million in 2023, then decreased by 22.63% to $174.7 million in 2024.
  • Business Quant data shows Assets Average for ORMP at $174.7 million in Q3 2024, $193.9 million in Q2 2024, and $212.1 million in Q1 2024.